NIH-funded research R01 grant

Using a painless nerve growth factor to speed up bone healing

Official title: Therapeutic Application of Painless Nerve Growth Factor to Accelerate Endochondral Fracture Repair

Funded at University of California, San Francisco · NIH-11162999 · Data updated 2026-11-12

This study is testing a new, easy-to-use injection that helps broken bones heal faster by delivering a special growth factor right where it's needed, making it a great option for people with conditions like diabetes or obesity that can slow down healing.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2025
Award (this year)$612,051
NIH project number7R01AR077761-04
Project IDNIH-11162999 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with fractures that are healing slowly or not at all, particularly those with additional health complications.

Less likely to help

Patients with fractures that are healing normally or those who do not have any complications affecting healing may not benefit from this research.

What this research studies

This research focuses on developing a new injectable treatment that uses a painless form of nerve growth factor to help heal fractures more quickly. The approach involves creating a biodegradable delivery system that releases this growth factor directly at the fracture site, which could be particularly beneficial for patients who experience delayed healing. The study aims to validate this method in clinical settings, especially for those with conditions that complicate healing, such as diabetes or obesity. By avoiding surgical interventions, this treatment could provide a less invasive option for patients.

Why it matters

Potential benefit: If successful, this research could significantly reduce healing times for fractures, improving recovery outcomes for patients.

How similar studies have gone: Previous research has shown promise in using nerve growth factors for bone healing, indicating that this approach could be effective.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Bahney, Chelsea Shields — University of California, San Francisco
  • Study coordinator: Bahney, Chelsea Shields

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.